Other studies have shown that Th9 cells can promote allergic reactions, activate mast cells, and aggregate pathological manifestation; adoption of Th9 cells in mice contributed to allergic airway inflammation, while anti-IL-9 treatment could alleviate airway inflammation as well as decrease airway hyperresponsiveness [9, 10]. The gene discussed is IL9; the disease is airway hyperresponsiveness.